- Macrophages from human pluripotent stem cells September 24, 2018
- Genome editing in induced pluripotent stem cells rescues TAF1 levels in X-linked dystonia-parkinsonism September 7, 2018
- FRMD8 promotes inflammatory and growth factor signalling by stabilising the iRhom/ADAM17 sheddase complex August 30, 2018
- Variant U1 snRNAs are implicated in human pluripotent stem cell maintenance and neuromuscular disease August 1, 2018
- Multiplex High-Throughput Targeted Proteomic Assay to Identify Induced Pluripotent Stem Cells July 8, 2018
DPhil Student | Industrial BBSRC Case Studentship | Lincoln College | email@example.com
Ben graduated from Sheffield University with a Master’s degree in molecular biology in 2014. Alongside his studies he worked in assay development for the biotech company R-Biopharm, and also took up a project at EMBL in Heidelberg working with mouse embryonic stem cells. His focus on stem cell biology continued during his Master’s degree, working for Pfizer in the field of regenerative medicine. He has recently handed in his DPhil thesis on naïve human pluripotency, which he completed jointly in the William James Lab (Sir William Dunn School of Pathology) and at F. Hoffmann-La Roche in Basel. Ben has now secured pre-seed funding to commercialise findings of his thesis and his specific interests are the role of miRNAs in pluripotency and gene-editing.